Search hospitals
>
South Carolina
>
Greenville
Prisma Health Cancer Institute - Faris
Claim this profile
Greenville, South Carolina 29605
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
322 reported clinical trials
8 medical researchers
Summary
Prisma Health Cancer Institute - Faris is a medical facility located in Greenville, South Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Prisma Health Cancer Institute - Faris is involved with conducting 322 clinical trials across 465 conditions. There are 8 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Suzanne R. Fanning.
Area of expertise
Breast Cancer
Prisma Health Cancer Institute - Faris has run 62 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Prisma Health Cancer Institute - Faris has run 60 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Ki Chung, MD
Prisma Health Cancer Institute - Eastside
7 years of reported clinical research
Aniket Saha
BI-LO Charities Children's Cancer Center
8 years of reported clinical research
Jeffrey K. Giguere
Prisma Health Cancer Institute - Faris
9 years of reported clinical research
Suzanne R. Fanning
Prisma Health Cancer Institute - Eastside
1 year of reported clinical research
Clinical Trials running at Prisma Health Cancer Institute - Faris
Breast Cancer
Lung Cancer
Breast cancer
Colorectal Cancer
Cancer
Bladder Cancer
Pancreatic Cancer
Ovarian Cancer
Prostate Cancer
Kidney Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting
2 awards
Phase 3
19 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting
2 awards
Phase 3
23 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Prisma Health Cancer Institute - Faris?
Prisma Health Cancer Institute - Faris is a medical facility located in Greenville, South Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Prisma Health Cancer Institute - Faris is involved with conducting 322 clinical trials across 465 conditions. There are 8 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Suzanne R. Fanning.
Where is Prisma Health Cancer Institute - Faris located?
The Prisma Health Cancer Institute - Faris Hospital is located at 900 W. Faris Road, Greenville, SC 29605.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Prisma Health Cancer Institute–Faris Road: - **Financial Assistance**: Visit the Prisma Health financial assistance page for general information. - **Hospital Patient Accounts**: Call 864-454-9604 or toll-free 1-844-302-8298 for billing and insurance inquiries. - **Physician Practice Patient Billing**: For billing questions, contact 864-797-6980 or toll-free 1-844-644-3160.
What insurance does Prisma Health Cancer Institute - Faris accept?
The Prisma Health Cancer Institute - Faris accepts a range of insurance plans such as Absolute Total Care - Ambetter, Absolute Total Care Medicaid, Aetna, Aetna Medicare, Allwell Medicare - Absolute Total Care, BCBS, BCBS Blue Cross, and UnitedHealthcare. It is recommended to directly contact the providers or facilities within the Institute to confirm the acceptance of specific insurance plans.
What awards or recognition has Prisma Health Cancer Institute - Faris received?
The Prisma Health Cancer Institute - Faris, located in Greenville, South Carolina, has received an $8.2 million award from the National Cancer Institute for outstanding research contributions through the National Cancer Institute Community Oncology Research Program. This institute is dedicated to the protection of human subjects in research, holding a Federalwide Assurance (FWA).
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.